Department of Obstetrics, Gynecology and Reproductive Sciences, Yale Stem Cell Center, Yale University School of Medicine, New Haven, CT, USA.
Cell Cycle. 2013 Jan 1;12(1):88-97. doi: 10.4161/cc.23028. Epub 2012 Dec 19.
Emerging evidence suggests that the tumor microenvironment plays a critical role in regulating cancer stem cells (CSCs) and tumor progression through both autocrine and paracrine signaling. Elevated production of bone morphogenetic proteins (BMPs) from human ovarian cancer cells and stroma has been shown to increase CSC proliferation and tumor growth. Here, we report that Lin28, a stem cell factor, binds to BMP4 mRNA in epithelial ovarian carcinoma cells, thereby promoting BMP4 expression at the post-transcriptional level. As co-expression of Lin28 and Oct4 (another stem cell factor) has been implicated in ovarian cancer CSCs, we also determined that high levels of Lin28 are associated with an unfavorable prognosis when co-expressed with high levels of Oct4. Together, these findings uncover a new level of regulation of BMP4 expression and imply a novel Lin28/Oct4/BMP4-mediated mechanism of regulating ovarian tumor cell growth, thus holding potential for the development of new strategies for the diagnosis and treatment of ovarian cancer.
新出现的证据表明,肿瘤微环境通过自分泌和旁分泌信号在调节癌症干细胞(CSC)和肿瘤进展方面起着关键作用。已经表明,人卵巢癌细胞和基质中骨形态发生蛋白(BMPs)的产量升高会增加 CSC 的增殖和肿瘤生长。在这里,我们报告说,干细胞因子 Lin28 与人卵巢癌细胞中的 BMP4 mRNA 结合,从而在转录后水平促进 BMP4 的表达。由于 Lin28 和 Oct4(另一种干细胞因子)的共表达与卵巢癌 CSC 有关,我们还确定了当与高水平的 Oct4 共表达时,高水平的 Lin28 与不良预后相关。总之,这些发现揭示了 BMP4 表达的新调节水平,并暗示了 Lin28/Oct4/BMP4 介导的调节卵巢肿瘤细胞生长的新机制,因此为开发卵巢癌的新诊断和治疗策略提供了潜力。